81 results
8-K
EX-10.2
KPRX
Kiora Pharmaceuticals Inc
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-10.2
qeborvo1 frhao
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
8-K
EX-10.1
udpq 4gvwf42
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
8-K
EX-10.3
ho9d9f
3 Feb 23
Kiora Pharmaceuticals Enters Into Two Equity Purchase Agreements with Lincoln Park Capital
7:01am
8-K
EX-10.4
442e3you40i7 97s9n
3 Feb 23
Kiora Pharmaceuticals Enters Into Two Equity Purchase Agreements with Lincoln Park Capital
7:01am
8-K
EX-10.1
5qmovups
3 Feb 23
Kiora Pharmaceuticals Enters Into Two Equity Purchase Agreements with Lincoln Park Capital
7:01am
8-K
EX-10.2
gljf1
3 Feb 23
Kiora Pharmaceuticals Enters Into Two Equity Purchase Agreements with Lincoln Park Capital
7:01am
8-K
EX-10.1
l1nld3
21 Nov 22
Kiora Pharmaceuticals Enters Into Agreements to Raise $3.12 Million
7:00am
8-K
EX-10.1
ccnefbf kc
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
8-K
EX-10.1
0qk zb6ufl0lp
26 Apr 22
Departure of Directors or Certain Officers
6:51am
8-K
EX-10.1
cvqycmp 04k
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-10.1
6ep676ku 8oqdctsdyc
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-10.1
8i6yka8 wi
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.2
bvhm g1qe5
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
4g48idfx xry2
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm